X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Elder Pharma with AJANTA PHARMA - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ELDER PHARMA vs AJANTA PHARMA - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ELDER PHARMA AJANTA PHARMA ELDER PHARMA/
AJANTA PHARMA
 
P/E (TTM) x -0.2 21.9 - View Chart
P/BV x 0.1 9.5 1.1% View Chart
Dividend Yield % 0.0 0.6 -  

Financials

 ELDER PHARMA   AJANTA PHARMA
EQUITY SHARE DATA
    ELDER PHARMA
Jun-14
AJANTA PHARMA
Mar-16
ELDER PHARMA/
AJANTA PHARMA
5-Yr Chart
Click to enlarge
High Rs3801,720 22.1%   
Low Rs1881,103 17.0%   
Sales per share (Unadj.) Rs491.2194.6 252.4%  
Earnings per share (Unadj.) Rs-3.245.2 -7.0%  
Cash flow per share (Unadj.) Rs14.450.3 28.6%  
Dividends per share (Unadj.) Rs08.00 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs376.5132.0 285.2%  
Shares outstanding (eoy) m20.5488.77 23.1%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x0.67.3 8.0%   
Avg P/E ratio x-89.331.2 -286.0%  
P/CF ratio (eoy) x19.728.1 70.2%  
Price / Book Value ratio x0.810.7 7.1%  
Dividend payout %017.7 0.0%   
Avg Mkt Cap Rs m5,833125,299 4.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,1792,570 84.8%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m10,08917,275 58.4%  
Other income Rs m257166 154.3%   
Total revenues Rs m10,34617,442 59.3%   
Gross profit Rs m-7925,807 -13.6%  
Depreciation Rs m361451 80.2%   
Interest Rs m2,75649 5,636.6%   
Profit before tax Rs m-3,6535,474 -66.7%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m3,7130-   
Tax Rs m1251,460 8.6%   
Profit after tax Rs m-654,014 -1.6%  
Gross profit margin %-7.833.6 -23.3%  
Effective tax rate %-3.426.7 -12.8%   
Net profit margin %-0.623.2 -2.8%  
BALANCE SHEET DATA
Current assets Rs m9,2407,639 121.0%   
Current liabilities Rs m9,9982,715 368.3%   
Net working cap to sales %-7.528.5 -26.3%  
Current ratio x0.92.8 32.8%  
Inventory Days Days4643 107.1%  
Debtors Days Days6079 76.2%  
Net fixed assets Rs m10,1246,914 146.4%   
Share capital Rs m206177 116.3%   
"Free" reserves Rs m5,58211,442 48.8%   
Net worth Rs m7,73411,721 66.0%   
Long term debt Rs m4,889149 3,287.8%   
Total assets Rs m22,88214,814 154.5%  
Interest coverage x-0.3112.9 -0.3%   
Debt to equity ratio x0.60 4,982.9%  
Sales to assets ratio x0.41.2 37.8%   
Return on assets %11.827.4 42.9%  
Return on equity %-0.834.2 -2.5%  
Return on capital %22.346.5 47.9%  
Exports to sales %3.055.1 5.5%   
Imports to sales %0.46.0 7.1%   
Exports (fob) Rs m3079,527 3.2%   
Imports (cif) Rs m431,038 4.2%   
Fx inflow Rs m30710,422 2.9%   
Fx outflow Rs m1251,678 7.5%   
Net fx Rs m1818,744 2.1%   
CASH FLOW
From Operations Rs m11,7543,264 360.1%  
From Investments Rs m-561-2,093 26.8%  
From Financial Activity Rs m-6,762-1,186 570.3%  
Net Cashflow Rs m4,432-15 -29,943.9%  

Share Holding

Indian Promoters % 39.6 73.8 53.7%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 7.5 1.6 483.9%  
FIIs % 16.8 7.6 221.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 36.1 17.0 212.4%  
Shareholders   16,479 20,968 78.6%  
Pledged promoter(s) holding % 77.6 4.4 1,766.7%  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ELDER PHARMA With:   SHASUN PHARMA  WYETH LTD  ABBOTT INDIA  ALEMBIC LTD  DR. REDDYS LAB  

Compare ELDER PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Down Over 290 Points; Metal Stocks Witness Losses(11:30 am)

After opening the day in the red, Indian share markets continued to witness selling pressure on the back of North Korea tensions.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

India's Big and Messy Real Estate Ponzi Scheme, Just Got Messier(Vivek Kaul's Diary)

Sep 11, 2017

The question is, whether real estate buyers are financial creditors or not.

The Recipe to Over 60% Returns in Less Than a Year(The 5 Minute Wrapup)

Sep 9, 2017

Short term crisis in some companies could unveil some great investing opportunities.

Feeling Left Out? Two Opportunities to Make Money in This Market(Daily Profit Hunter)

Sep 13, 2017

Nifty is above 10,000 once again. Have you missed the bus?

Introducing Smart Contrarian: The Blueprint for Big Profits from Small Investments

Sep 18, 2017

Welcome to a bold, new initiative designed for the truly contrarian investor.

How To Link Aadhaar With Your Mutual Fund Investments(Outside View)

Sep 11, 2017

The Government has extended the linking of the unique Aadhaar number to nearly all financial transactions.

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ELDER PHARMA SHARE PRICE


Sep 12, 2016 (Close)

TRACK ELDER PHARMA

  • Track your investment in ELDER PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

ELDER PHARMA - ALEMBIC PHARMA COMPARISON

COMPARE ELDER PHARMA WITH

MARKET STATS